Skip to main content
Why biopharma resilience depends on education and training
Health News
News, information and personal stories
Oncology
Life sciences
Men's Healthcare
Clinical Trials
More
About us
Healthcare
Rare Diseases
About us
Healthcare
Rare Diseases
Life Sciences Q2 2024
Launch of strategic priorities at impact conference in Cork
Life Sciences Q2 2024
Navigating Europe’s genomic landscape to drive progress in personalised medicine
Life sciences
Our campaign partners
Life Sciences Q2 2024
The pros and cons of shipping by air
Sponsored
Expanded Irish facility supports production of essential materials for advancing drug delivery
Sponsored
Creating better medicines with greater efficiency and speed
Life Sciences Q2 2024
Why life sciences remains a key pillar in Ireland’s economic stability and growth
Irish life sciences facilities nationwide create jobs, impact capital expenditure and are a source of materials and services. Irish-based companies supplying the industry amplify this impact. Home to 13 of the world’s top 15 pharma companies and 14 of the largest 15 medtech companies, Ireland is one of the world’s leading locations for life sciences. … Continued
Life Sciences Q2 2024
What’s needed to safeguard stable medicines development
Sponsored
World-class expertise and infrastructure powering life sciences research
Life Sciences Q2 2024
Convert scientific curiosity into a career as demand for STEM skills rises
Life Sciences Q2 2024
Why biopharma resilience depends on education and training
Sponsored
How CDMOs support innovative drug launches
Life Sciences Q2 2024
How a national strategy will help Irish medtech get ahead
The medtech industry in Ireland is constantly evolving and is now perfectly equipped to advance our position as a global leader. Ireland is recognised as a global medtech hub, with 450 companies employing 48,000 people to deliver €13 billion in medtech exports, enabling life-changing innovation. Research and growth in global medtech The average medtech worldwide … Continued
Life sciences
How can we leverage drug development in life sciences in Ireland?
Life sciences
The ever-more personalised approach in treatment development
Life sciences
Addressing the manufacturing challenges of Brexit
Life sciences
How bioengineering and working with industry partners push the boundaries of personalised medicine
Life sciences
Irish medtech targets connected health market worth €15.5bn by 2024